SYNH — Syneos Health Income Statement
0.000.00%
Last trade - 00:00
HealthcareAdventurousLarge Cap
- $4.46bn
- $7.08bn
- $5.39bn
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,390 | 4,676 | 4,416 | 5,213 | 5,393 |
Cost of Revenue | |||||
Gross Profit | 956 | 1,038 | 1,018 | 1,218 | 1,254 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 4,234 | 4,428 | 4,117 | 4,827 | 4,991 |
Operating Profit | 156 | 248 | 299 | 386 | 402 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 57.3 | 102 | 204 | 315 | 315 |
Provision for Income Taxes | |||||
Net Income After Taxes | 23.1 | 131 | 193 | 235 | 266 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 24.3 | 131 | 193 | 235 | 266 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 24.3 | 131 | 193 | 235 | 266 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.681 | 1.83 | 2.31 | 2.42 | 3.05 |